Abstract:Background Limited studies have involved new‐onset hypertriglyceridemia, and this study was to evaluate the associations of hypertriglyceridemia onset age with cardiovascular diseases (CVD) and all‐cause mortality. Methods and Results This population‐based prospective study enrolled 98 779 participants free of hypertriglyceridemia and CVD at baseline in the Kailuan study initiated in June 2006. All participants underwent health checkups biennially until December 2017, and a total of 13 832 participants developed new hypertriglyceridemia. A 1:1 age‐ (±1 year) and sex‐matched analysis was applied to select control subject of the same year for each new‐onset case. There were 13 056 case‐control pairs included. The total follow‐up time was 179 409 person‐years, with a median follow‐up time of 7.0 years. Primary outcomes were CVD and all‐cause mortality, and hazard ratios were estimated after adjustment for baseline characteristics. A total of 807 incident CVD events and 600 all‐cause mortality events were documented. After multivariable adjustment, participants with hypertriglyceridemia onset age <45 years had the highest risk compared with matched controls, with hazard ratios of 2.61 (95% CI, 1.59–4.27) for CVD, 4.69 (95% CI, 2.34–9.40) for all‐cause mortality, 2.23 (95% CI, 0.67–7.38) for myocardial infarction, and 2.68 (95% CI, 1.56–4.62) for stroke. The risk estimates gradually decreased with each decade increase in the onset age of hypertriglyceridemia. Conclusions Among Chinese adults, hypertriglyceridemia identified at an earlier onset age was associated with higher risks for CVD and all‐cause mortality. Clinical Perspective What Is New? New‐onset hypertriglyceridemia was associated with increased risks for incident cardiovascular diseases (CVD) and all‐cause mortality independent of traditional risk factors. Hypertriglyceridemia identified at an earlier onset age was associated with higher risks for CVD and all‐cause mortality. The new‐onset hypertriglyceridemia–related CVD risk was mainly driven by an increase in stroke incidence among Chinese adults. What Are the Clinical Implications? Hypertriglyceridemia onset age was a vital determinant of CVD and all‐cause mortality. Association in younger onset, although strong, earlier identification and prevention targeting hypertriglyceridemia would favorably influence CVD and all‐cause mortality. Cardiovascular disease (CVD) remains the leading cause of mortality in adults worldwide, 1 and lipid metabolism disorders are significant risk factors for the development of CVD and all‐cause mortality. 2 The onset trend for lipid metabolism disorders at a progressively younger age 3 , 4 is consistent with increasing incidence among young individuals with CVD. 5 , 6 Furthermore, lowering low‐density lipoprotein cholesterol (LDL‐C) levels in the middle‐aged and older population is associated with a marked reduction in CVD and mortality risk. 6 , 7 Previous studies have demonstrated that residual cardiovascular risk persists even though LDL‐C is reduced to the recommended target, and this residual risk may be attributed to atherosclerotic dyslipidemia, including elevated triglycerides. 8 Although Criqui et al 9 and Angelantonio et al 10 reported no independent association between plasma triglyceride levels and CVD and mortality, emerging studies have documented a positive relationship between elevated triglycerides and increased risk of CVD and mortality, 11 , 12 , 13 and the American Heart Association has embraced the view. 8 The effect of risk factors on adverse events depends not only on the amount but also on the duration of exposure. Studies have noted that the association between risk factors and the development of diseases is age‐dependent, and the risk of CVD related to new‐onset hypertension or diabetes generally declines with onset aging. 14 , 15 However, neither the Copenhagen City Heart Study 11 , 12 , 13 nor the LRCFS 9 and ERFC Study 10 could determine the association between the age of onset of elevated triglycerides and incident CVD and mortality, which may lead to bias in risk estimates, causing an incons -Abstract Truncated-

Association of Lipid, Inflammatory and Metabolic Biomarkers with Age at Onset for Incident Cardiovascular Disease

Clinical Usefulness Of Metabolic Risk Factors To Identify Young Asymptomatic Women Adults With Subclinical Atherosclerosis: A Cross-Sectional Study

Associations of Clinical Risk Factors and Novel Biomarkers with Age at Onset of Type 2 Diabetes.

Association of Age of Metabolic Syndrome Onset With Cardiovascular Diseases: The Kailuan Study

Age-specific modifiable risk factor profiles for cardiovascular disease and all-cause mortality: a nationwide, population-based, prospective cohort study

Associations of Hypertriglyceridemia Onset Age With Cardiovascular Disease and All‐Cause Mortality in Adults: A Cohort Study

Transitions in Metabolic Health and Onset Age of Cardiovascular Diseases

Individual and Combined Cardiometabolic Morbidities and the Subsequent Risk of Cardiovascular Events in Chinese Adults.

Age at diagnosis, diabetes duration and the risk of cardiovascular disease in patients with diabetes mellitus: a cross-sectional study

Lifetime Risk for Cardiovascular Disease in a Chinese Population: the Chinese Multi–Provincial Cohort Study

Association of Multitrajectories of Lipid Indices With Premature Cardiovascular Disease: A Cohort Study

Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease

Association Between Age at Diagnosis of Type 2 Diabetes and Cardiovascular Diseases: A Nationwide, Population-Based, Cohort Study

Risk Factors of Premature Atherosclerotic Cardiovascular Disease in China: A Longitudinal Analysis of the China Health and Nutrition Survey Cohort

Individual and Combined Associations of Modifiable Lifestyle and Metabolic Health Status With New-Onset Diabetes and Major Cardiovascular Events: The China Cardiometabolic Disease and Cancer Cohort (4C) Study

Ranking Age-Specific Modifiable Risk Factors for Cardiovascular Disease and Mortality: Evidence from a Population-Based Longitudinal Study

Long-term Risks for Cardiovascular Disease and Mortality Across the Glycaemic Spectrum in a Male-Predominant Chinese Cohort Aged 75 Years or Older: the Kailuan Study.

Abstract 17952: Age-Dependent Disparities on Associations of Socioeconomic, Lifestyle, and Metabolic Risk Factors With Major Cardiovascular Diseases and Mortality

Age-specific differences in the association between prediabetes and cardiovascular diseases in China: A national cross-sectional study

Differences in Clinical Profiles and Outcomes Between Early-onset and Older Patients Hospitalized for Coronary Artery Disease: A Prospective Cohort Study.

Body Size, Insulin Sensitivity, Metabolic Health and Risk of Cardiovascular Disease in Chinese Adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) Study.